L. Wittkop, L. Esterle, P. Sogni, Y. Benhamou, P. Trimoulet et al., Clinical Centres (ward/participating physicians

/. A. Virologie and . Krivine,

/. F. Anatomo-pathologie and . Charlotte,

/. S. Virologie and . Fourati,

I. Poizot-martin, O. Zaegel, and A. Ménard,

/. Virologie, Tamalet

M. Infectieuses, /. G. Tropicales, P. Pialoux, F. Bonnard, L. Bani-sadr et al.,

/. C. Virologie and . Le-pendeven,

. Chu-purpan-toulouse,

/. F. Virologie and . Nicot,

/. J. Infectiologie and . Durant,

/. J. Anatomo-pathologie and M. C. Haudebourg,

/. Y. Virologie and . Baazia,

/. F. Virologie and . Nicot,

C. Bichatclaude-bernard,

/. P. Virologie and . Palmer,

P. M. Girard, K. Lacombe, P. Campa;-anatomo-pathologie, /. D. Wendum, P. Cervera et al., Maladies Infectieuses et Tropicales

/. N. Virologie and . Harchi,

C. Bicêtre-(médecine-interne, /. J. Delfraissy, C. Goujard, and Y. Quertainmont,

, Virologie/C. Pallier)

C. Paul-brousse,

/. P. Anatomo-pathologie and . Bioulac-sage,

/. P. Virologie, S. Trimoulet, ;. Reigadas, A. Beniken, A. Ritleng et al., Lagorse Conflicts of interest

, Bruno Spire declared consultancy for Merck Sharp & Dohme-Chibret (MSD) and Gilead companies; payment for lectures from MSD, Gilead and Jensen; and travel/accommodation/meeting expenses paid by MSD

, MILDECA. Interministerial mission for combating drugs and addictive behaviours website, p.11, 2016.

L. Brunet, E. E. Moodie, and K. Rollet, Marijuana smoking does not accelerate progression of liver disease in HIV-hepatitis C coinfection: a longitudinal cohort analysis, Clin Infect Dis, vol.57, pp.663-70, 2013.

P. Roux, B. Demoulin, and P. Sogni, La co-infection par le virus de l'hépatite C chez les personnes infectées par le VIH : données de l'enquête ANRSVespa2, Bull Epidémiologique, pp.314-334, 2013.

J. M. Wallace, J. S. Oishi, R. G. Barbers, M. S. Simmons, and D. P. Tashkin, Lymphocytic subpopulation profiles in bronchoalveolar lavage fluid and peripheral blood from tobacco and marijuana smokers, Chest, vol.105, pp.847-52, 1994.

C. Chao, L. P. Jacobson, and D. Tashkin, Recreational drug use and T lymphocyte subpopulations in HIV-uninfected and HIV-infected men, Drug Alcohol Depend, vol.94, pp.165-71, 2008.
DOI : 10.1016/j.drugalcdep.2007.11.010

URL : http://europepmc.org/articles/pmc2691391?pdf=render

J. T. Lee, B. E. Shepherd, and J. R. Koethe, Active marijuana Use was not associated with changes in body mass index or CD4 T-cell counts in HIVinfected patients (poster), ID week, 2014.

D. I. Abrams, J. F. Hilton, and R. J. Leiser, Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial, Ann Intern Med, vol.139, pp.258-66, 2003.

B. M. Bredt, D. Higuera-alhino, S. B. Shade, S. J. Hebert, J. M. Mccune et al., Short-term effects of cannabinoids on immune phenotype and function in HIV-1-infected patients, J Clin Pharmacol, vol.42, pp.82-89, 2002.

U. R. Montarroyos, D. B. Miranda-filho, and C. C. César, Factors related to changes in CD4+ T-cell counts over time in patients living with HIV/AIDS: a multilevel analysis, PLoS One, vol.9, p.84276, 2014.

R. K. Lodwick, M. A. Johnson, and C. J. Smith, Effect of patient smoking status on CD4 count change after initiation of antiretroviral therapy, Royal Free HIV Cohort Database, issue.11, 2016.

L. P. Park, J. B. Margolick, and J. V. Giorgi, Influence of HIV-1 infection and cigarette smoking on leukocyte profiles in homosexual men, The Multicenter AIDS Cohort Study J Acquir Immune Defic Syndr, vol.5, pp.1124-1154, 1992.

R. A. Royce and W. Winkelstein, HIV infection, cigarette smoking and CD4+ Tlymphocyte counts: preliminary results from the San Francisco Men's Health Study, AIDS, vol.4, pp.327-360, 1990.

M. Loko, D. Salmon, and P. Carrieri, The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): early findings, BMC Infect Dis, vol.10, p.303, 2006.
URL : https://hal.archives-ouvertes.fr/pasteur-01070193

F. Marcellin, P. Roux, and M. Winnock, Using patient-reported outcomes to improve the management of co-infection with HIV and HCV: the ANRS CO13 HEPAVIH cohort, Expert Rev Gastroenterol Hepatol, vol.8, pp.351-359, 2014.

F. Beck, J. Richard, R. Guignard, L. Nézet, O. Spilka et al., Les niveaux d'usage des drogues en France en 2014 (Inpes OFDT), 2015.

M. P. Carrieri, V. Villes, and F. Raffi, Self-reported side-effects of antiretroviral treatment among IDUs: a 7-year longitudinal study (APROCOCOPILOTE COHORT ANRS CO-8), Int J Drug Policy, vol.18, pp.288-95, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00167849

K. M. Martens and D. G. Gilbert, Marijuana and tobacco exposure predict affectregulation expectancies in dual users, Addict Behav, vol.33, pp.1484-90, 2008.

R. E. Schane, P. M. Ling, and S. A. Glantz, Health effects of light and intermittent smoking: a review, Circulation, vol.121, pp.1518-1540, 2010.

R. E. Schane, S. A. Glantz, and P. M. Ling, Social smoking implications for public health, clinical practice, and intervention research, Am J Prev Med, vol.37, pp.124-155, 2009.

F. Marcellin, P. Roux, and M. Loko, High levels of alcohol consumption increase the risk of advanced hepatic fibrosis in HIV/hepatitis C viruscoinfected patients: a sex-based analysis using transient elastography at enrollment in the HEPAVIH ANRS CO13 cohort, Clin Infect Dis, vol.59, pp.1190-1192, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-01997182

K. Bush, D. R. Kivlahan, M. B. Mcdonell, S. D. Fihn, and K. A. Bradley, The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP), Arch Intern Med, vol.158, pp.1789-95, 1998.

P. Carrieri, V. Cailleton, L. Moing, and V. , The dynamic of adherence to highly active antiretroviral therapy: results from the French National APROCO cohort, J Acquir Immune Defic Syndr, vol.28, pp.232-241, 2001.

P. Roux, L. Fugon, and M. Winnock, Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users, Addiction, vol.107, pp.152-161, 2012.

, Laboratory guidelines for enumerating CD4 T lymphocytes in the context of HIV/AIDS, World Health Organization, Regional Office for South-East Asia, issue.11, 2007.

R. K. Sterling, E. Lissen, and N. Clumeck, Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection, Hepatology, vol.43, pp.1317-1342, 2006.

J. P. Tate, A. C. Justice, and M. D. Hughes, An internationally generalizable risk index for mortality after one year of antiretroviral therapy, AIDS, vol.27, pp.563-72, 2013.

S. L. Zeger and K. Y. Liang, Longitudinal data analysis for discrete and continuous outcomes, Biometrics, vol.42, pp.121-151, 1986.

. Who-expert-committee, Physical status: the use and interpretation of anthropometry-WHO technical report series 854, 1995.

T. W. Klein and G. A. Cabral, Cannabinoid-induced immune suppression and modulation of antigen-presenting cells, J Neuroimmune Pharmacol, vol.1, pp.50-64, 2006.

L. Nong, C. Newton, Q. Cheng, H. Friedman, M. D. Roth et al., Altered cannabinoid receptor mRNA expression in peripheral blood mononuclear cells from marijuana smokers, J Neuroimmunol, vol.127, pp.169-76, 2002.

A. Szulakowska and H. Milnerowicz, Cannabinoids-influence on the immune system and their potential use in supplementary therapy of HIV/AIDS, HIV AIDS-InTech, issue.11, 2011.

J. L. Croxford and T. Yamamura, Cannabinoids and the immune system: potential for the treatment of inflammatory diseases?, J Neuroimmunol, vol.166, pp.3-18, 2005.

R. Tanasescu and C. S. Constantinescu, Cannabinoids and the immune system: an overview, Immunobiology, vol.215, pp.588-97, 2010.

G. G. Nahas, A. Morishima, and B. Desoize, Effects of cannabinoids on macromolecular synthesis and replication of cultured lymphocytes, Fed Proc, vol.36, pp.1748-52, 1977.

M. El-gohary and M. A. Eid, Effect of cannabinoid ingestion (in the form of bhang) on the immune system of high school and university students, Hum Exp Toxicol, vol.23, pp.149-56, 2004.

S. C. White, S. C. Brin, and B. W. Janicki, Mitogen-induced blastogenic responses of lymphocytes from marihuana smokers, Science, vol.188, pp.71-73, 1975.

R. J. Lau, D. G. Tubergen, M. Barr, E. F. Domino, N. Benowitz et al., Phytohemagglutinin-induced lymphocyte transformation in humans receiving delta9-tetrahydrocannabinol, Science, vol.192, pp.805-812, 1976.

M. Milloy, B. Marshall, and T. Kerr, High-intensity cannabis use associated with lower plasma human immunodeficiency virus-1 RNA viral load among recently infected people who use injection drugs, Drug Alcohol Rev, vol.34, pp.135-175, 2015.

P. K. Peterson, G. Gekker, S. Hu, G. Cabral, and J. R. Lokensgard, Cannabinoids and morphine differentially affect HIV-1 expression in CD4(+) lymphocyte and microglial cell cultures, J Neuroimmunol, vol.147, pp.123-129, 2004.

R. B. Rock, G. Gekker, and S. Hu, 212-2-mediated inhibition of HIV1 expression in microglial cells: involvement of cannabinoid receptors, J Neuroimmune Pharmacol, vol.2, pp.178-83, 2007.

F. Beck, M. Tovar, S. Spilka, R. Guignard, and J. Richard, Les niveaux d'usage des drogues en France en 2010, exploitation des données du Baromètre santé, Tendances, vol.76, issue.11, 2010.

N. D. Volkow, R. D. Baler, W. M. Compton, and S. Weiss, Adverse health effects of marijuana use, N Engl J Med, vol.370, pp.2219-2246, 2014.

J. G. Feldman, H. Minkoff, and M. F. Schneider, Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women's interagency HIV study, Am J Public Health, vol.96, pp.1060-1065, 2006.

C. W. Claassen, M. Diener-west, S. H. Mehta, D. L. Thomas, and G. D. Kirk, Discordance between CD4+ T-lymphocyte counts and percentages in HIV-infected persons with liver fibrosis, Clin Infect Dis, vol.54, pp.1806-1819, 2012.

L. Degenhardt, A. J. Ferrari, and B. Calabria, The global epidemiology and contribution of cannabis use and dependence to the global burden of disease: results from the GBD 2010 study, PLoS One, vol.8, p.76635, 2013.

A. Fogarty, P. Rawstorne, G. Prestage, J. Crawford, J. Grierson et al., Marijuana as therapy for people living with HIV/AIDS: social and health aspects, AIDS Care, vol.19, pp.295-301, 2007.

A. Alberti, N. Clumeck, and S. Collins, Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients, J Hepatol, vol.42, pp.615-639, 2005.

D. Dhumeaux, P. Marcellin, and E. Lerebours, Treatment of hepatitis C. The 2002 French consensus, Gut, vol.52, pp.1784-1791, 2003.

J. P. Galmiche, French consensus conference on hepatitis C: screening and treatment, Gut, vol.42, pp.892-900, 1998.